#NuwellisNews: Nuwellis and DaVita Inc. extend supply and collaboration agreement pilot phase. Read more: https://lnkd.in/gJHUXMeF #Ultrafiltration #MedTech
Nuwellis, Inc.
Medical Equipment Manufacturing
Eden Prairie, Minnesota 2,759 followers
Restoring Fluid Balance. Transforming Care.
About us
We are Nuwellis, (Nasdaq: NUWE) formerly CHF Solutions. Our solutions go beyond chronic heart failure, so we’ve rebranded to reflect our therapeutic focus areas: heart failure, critical care, and pediatric fluid imbalance. We are a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. Our Aquadex SmartFlow® System gently removes fluid from adult and pediatric patients weighing 20 kg or more. Nuwellis consists of a purpose-driven team that puts patients and their providers at the center of everything we do. This is the new well. And for those whose lives and life’s work are transformed by our fluid management technologies, the new well is everything. Nuwellis is headquartered in Eden Prairie, Minn., with a wholly-owned subsidiary in Ireland. The Company has been listed on the Nasdaq Capital Market since February 2012, previously branded as CHF Solutions (Nasdaq: CHFS).
- Website
-
http://www.nuwellis.com
External link for Nuwellis, Inc.
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Eden Prairie, Minnesota
- Type
- Public Company
Locations
-
Primary
Get directions
12988 Valley View Rd
Eden Prairie, Minnesota 55344, US
Employees at Nuwellis, Inc.
-
Paul LaVoie
Sr. Product Manager at Boston Scientific
-
Ryan Marthaler
Senior Director | Product Marketing | Product Management | Medical Device
-
Neil Ayotte
Senior Vice President, General Counsel and Chief Compliance Officer at Nuwellis, Inc.
-
John Polejewski, MBA
Global Supply Chain Leaders | Supply Agreements , Contracts | Production Control | Inventory Management | ERP Systems Management | Purchasing |…
Updates
-
#NuwellisNews: Nuwellis announces purchase agreement with a 50 hospital network for Aquadex ultrafiltration therapy. Read more: https://lnkd.in/gDA8ajkU This new network-wide agreement signifies a broader commitment to providing advanced ultrafiltration technology for heart failure, critical care, and now pediatric patients. #Ultrafiltration #MedTech
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy
ir.nuwellis.com
-
#NuwellisNews: Nuwellis receives USPTO notice of patent allowance for innovative pediatric CRRT technology. Read more here: https://lnkd.in/g5n62ieQ This patent strengthens Nuwellis' IP portfolio and paves the way for the development of novel technology that allows healthcare providers to switch seamlessly between stationary operation and "transport" or "ambulation" mode, enabling unprecedented patient mobility. #Ultrafiltration #MedTech
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology | Nuwellis, Inc.
ir.nuwellis.com
-
#NuwellisNews: Nuwellis announces launch of ultrafiltration therapy using Aquadex SmartFlow® system at Henry Ford Health. Read more here: https://lnkd.in/g8FYwSRT #HeartFailure #Cardiology #Ultrafiltration #MedTech
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health | Nuwellis, Inc.
ir.nuwellis.com
-
Will you be at #AKICRRT in San Diego? Join Nuwellis and our strategic partner SeaStar Medical to learn more about Quelimmune™ and the latest innovations in #AKI therapies and #CRRT. Register today: https://lnkd.in/g2Kruna #AKICRRT2024 #SCDPED #NephPeds #MedTech
-
-
That’s a wrap on #THT2024! Thank you to the #HeartFailure leaders who connected with us in Boston, and special thanks to Drs. Maria Rosa Costanzo, Sean Pinney, Mark Hofmeyer, Aroti Hegde and Deya Alkhatib, MD for supporting our symposium and late-breaking presentations on #aquapheresis advancements. Did you miss us at the conference? Get in touch to learn more about innovative therapies for your patients with fluid overload: https://lnkd.in/gaSHi-th #FluidOverload #MedTech #Ultrafiltration #Cardiology
-
#NuwellisNews: Presented at #THT2024, late-breaking results from two new clinical data analyses from the AVOID-HF trial demonstrate the benefits of #Aquadex in helping to reduce heart failure events and hospitalization at 30 days: https://lnkd.in/gvC6KuiH 👆 Read the full press release for more about this new #ClinicalData. #HeartFailure #Cardiology #Ultrafiltration #MedTech
-
TOMORROW: Join us at #THT2024 for back-to-back late-breaking clinical abstract presentations! We’re looking forward to the insights from Sean Pinney and Deya Alkhatib, MD about how #aquapheresis can make a difference for heart failure patients with fluid overload. Comment below and let us know if we’ll see you there! #HeartFailure #FluidOverload #Cardiology
-
Very exciting! Congrats SeaStar! Can’t wait for the first patient treated under the HDE approval!
Big news from the Big Apple – read more from the official @US_FDA website HERE: https://lnkd.in/grtrMj9V Thank you @nasdaq for the great shot! #fdapproval #nasdaq #icu
-
-
Today’s the day! ⏰ Join us in Grand Ballroom A-B, Concourse Level at #THT2024 to discover the latest technological and clinical developments in #aquapheresis therapy for #HeartFailure patients. See you at 6:00 PM EST! #Cardiology #Ultrafiltration #MedTech
-